Read it again. We're looking at late 2014 into 2015 when this drug will start bringing in revenue. Do they have enough cash to get them to 2015 or do they have to dilute some more?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.